Skip to main content
logo
Molbio Diagnostics Limited (BOM:544866)
India flag India · Delayed Price · Currency is INR
1,312.65
-48.75 (-3.58%)
At close: Sep 16, 2026

Molbio Diagnostics Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
17,54414,45710,2048,3663,325
Revenue Growth
109.71%41.68%21.98%151.63%-
Gross Profit
10,5318,5895,9704,9051,847
Operating Income
3,7812,6702,2311,942136.37
Net Income
2,4911,6661,4511,020-7.26
Earnings Per Share
22.0914.7712.879.04-0.06
EPS Growth
144.37%14.76%42.37%--

Revenue by Geography
Chart
Fiscal YearFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '25 Mar '24 Mar '23
India
13,0668,2337,5432,838
outside India
1,3901,971822.48487.1
Total
14,45710,2048,3663,325

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
3,7063,7061,291222.1972.39
Total Debt
4,5014,5011,4691,8361,185
Net Cash (Debt)
-794.59-794.59-178.78-1,614-1,113
Net Cash Growth
-----
Net Cash Per Share
-7.05-7.05-1.59-14.31-9.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-503.852,87195.7641.32
Capital Expenditures
--500.22-546.61-263.68-144.98
Free Cash Flow
-3.632,324-167.98496.34
Free Cash Flow Growth
--99.84%---

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
60.03%59.41%58.51%58.63%55.55%
Operating Margin
21.55%18.47%21.87%23.21%4.10%
Pretax Margin
19.28%15.99%19.05%15.50%2.87%
Profit Margin
14.20%11.52%14.22%12.19%-0.22%
FCF Margin
-0.03%22.78%-2.01%14.93%